Paradromics, Inc.

Austin, Texasparadromics.com

Paradromics is a neurotechnology company developing a high-performance brain-computer interface (BCI) platform that records individual neuron activity and uses AI algorithms to translate brain signals into actionable health data. Their flagship product, the Connexus® BCI, targets restoring communication for patients with paralysis from ALS, spinal cord injuries, and stroke, with FDA approval for the Connect-One clinical study. The platform addresses unmet medical needs in brain health, including movement disorders, chronic pain, addiction, and depression.